Emotion Regulation Intervention to Sustain Physical Activity in Rural-dwelling Women and Men After Myocardial Infarction
- Conditions
- Cardiac EventEmotions
- Interventions
- Behavioral: eMotionBehavioral: Healthy Living Active Control
- Registration Number
- NCT04441086
- Lead Sponsor
- Indiana University
- Brief Summary
The purpose of this study is to evaluate early preliminary efficacy of the eMotion intervention in US adults who have experienced a first cardiac event and participating in phase II cardiac rehabilitation.
This study will evaluate early efficacy and evaluate the cognitive processes as intervention response variables. Investigators will also examine the relationships between emotion regulation and other cognitive processes and symptoms (threat and stress, cognition and motivation), symptoms \[depression, anxiety, pain, sleep, and fatigue\]), and health related quality of life among adults enrolled in cardiac rehabilitation after a first cardiac event.
- Detailed Description
Aim 1: Evaluate early preliminary efficacy of the eMotion intervention
Research hypothesis 1. Compared with adults randomized to active healthy living attention control and usual care control groups, adults randomized to eMotion will have greater improvement in these outcomes over time:
1.1. Improved minutes of moderate to vigorous physical activity 1.2. Symptom improvement (depression, anxiety, pain, sleep, and fatigue) 1.3. Health related quality of life.
Aim 2: Evaluate the cognitive processes as intervention response variables.
Research hypothesis 2. Compared with adults randomized to active healthy living attention control and usual care control groups, adults randomized to eMotion will have:
2.1. Improved emotion regulation (efficiency and strategy use) 2.2. Decreased perceived cardiac threat and general stress 2.3. Improved cognition and motivation
Aim 3. Exploratory. Examine the relationships between emotion regulation and other cognitive processes and symptoms (threat and stress, cognition and motivation), and symptoms \[depression, anxiety, pain, sleep, and fatigue\]) among adults enrolled in cardiac rehabilitation after a first major cardiac event.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- First time major cardiac event as documented in medical record;
- enrolled in cardiac rehabilitation phase II program;
- living independently; and
- at least mild symptoms of depression and/or anxiety (determined by standardized measure cutpoints).
Exclusion criteria:
- does not speak English;
- major Axis 1 psychiatric diagnosis (e.g. schizophrenia);
- terminal cancer; and
- legally blind
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description eMotion eMotion The eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for aging rural adults following a first cardiac event in tandem with usual cardiac rehabilitation. The intervention helps patients recognize their emotions, balance emotional and physical wellbeing, and implement emotion regulation strategies effectively. Intervention provided in addition to usual cardiac rehabilitation. Healthy living active control Healthy Living Active Control Healthy living strategies based on American Heart Association education. Intervention provided in addition to usual cardiac rehabilitation.
- Primary Outcome Measures
Name Time Method Change in Moderate to Vigorous Physical Activity (MVPA) 1 week trials at baseline, 12 weeks, 20 weeks, and 52 weeks Minutes spent in MVPA
- Secondary Outcome Measures
Name Time Method Change in Fatigue Symptoms Baseline to 12 weeks, 20 weeks, and 52 weeks Fatigue will be measured using the Fatigue Severity Scale
Change in Depression Symptoms Baseline to 12 weeks, 20 weeks, and 52 weeks Symptoms of depression measured using the Depression, Anxiety, and Stress Scale (DASS)
Change in Anxiety Symptoms Baseline to 12 weeks, 20 weeks, and 52 weeks Symptoms of anxiety measured using the Depression, Anxiety, and Stress Scale (DASS)
Change in Pain Symptoms Baseline to 12 weeks, 20 weeks, and 52 weeks Pain will be measured with the Brief Pain Inventory
Change in Sleep efficiency Baseline to 12 weeks, 20 weeks, and 52 weeks Sleep efficiency will be a calculation of the ratio of the total sleep time to time spent in bed using the ActiGraph wGT3X-BT accelerometer
Trial Locations
- Locations (4)
Indiana University Health Bedford Hospital
🇺🇸Bedford, Indiana, United States
Indiana University Health West Hospital
🇺🇸Avon, Indiana, United States
Indiana University Health Methodist Hospital
🇺🇸Indianapolis, Indiana, United States
Indiana University Health Tipton Hospital
🇺🇸Tipton, Indiana, United States